11th November 2021, Padova, Italy. The kick-off meeting of LIFESAVER – Living Impact on Foetal Evolution, a Horizon 2020 project, was held on the 11th November 2021. The scope of the project is to develop an in-vitro and in silico cores to test embryonic toxicity from pharmaceuticals and environment chemicals. The model will also include Simulation Process Data Management, nanotechnology, bioprinting, biosensors and computational fluid-dynamics for the non-invasive monitoring of human embryo development. Project Adviser Dr. Roberto Ensenat-Waser from the European Research Agency, in his introduction, noted that the LIFESAVER project will also have the responsibility to feedback to EU policy on such Clean Chemicals and Novel Toxicology Assessment Models and their use and application in future. This project falls within the Commission’s Green Deal effort that includes assessing risks arising from the use of chemicals. This project will help identify risks in human embryos by gaining a better understanding of exposure and dosage of single as well as chemical mixtures including plastics. Dr Michael Gasik professor at Aalto University Finland and Director at Seqvera, who put together this successful Euro 6 million H2020 project application, was in Malta in October to discuss the execution of the Work Packages with Ing Joseph P Sammut, Director at Malta Innovation Hub at the Malta Life Sciences Park who is the Maltese partner in the 14-partner project. Ing Sammut is past Chairman and CEO of the Malta Life Sciences Park who lead the Euro 30M European Funds funding application and project execution. The commitment on the funding also included networking and participation in multi-partner research projects. The Malta Innovation Hub is a Malta Enterprise project.